ASTEC — Astec Lifesciences Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsAdventurousSmall CapNeutral

Annual income statement for Astec Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,226	5,549	6,766	6,282	4,582
Cost of Revenue
Gross Profit	1,476	1,781	2,369	1,695	1,389
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	4,604	4,690	5,569	5,850	5,003
Operating Profit	622	859	1,197	431	-422
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	614	891	1,211	349	-617
Provision for Income Taxes
Net Income After Taxes	475	651	899	256	-469
Minority Interest
Net Income Before Extraordinary Items
Net Income	475	650	899	256	-469
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	475	650	899	256	-469
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	24.3	33.2	45.8	13.2	-23.9
Dividends per Share